Thom T., Haase N., Rosamond W. et al. Heart disease and stroke statistics — 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation2006; 113: 85—151.
2.
Kleindorfer D., Panagos P., Pancioli A. et al. Incidence and short-term prognosis of transient ischemic attack in a population-based study . Stroke2005; 36: 720—3.
3.
White H., Boden-Albala B., Wang C. et al. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation2005; 111: 1327—31.
4.
Bamford J., Sandercock P., Dennis M., Burn J., Warlow C.Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet1991; 337: 1521—6.
5.
Gorelick PBDistribution of atherosclerotic cerebrovascular lesions. Effects of age, race, and sex. Stroke1993; 24: 116—9.
6.
Sacco RL, Kargman DE, Gu Q., Zamanillo MCRace-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke1995; 26: 14—20.
7.
Wityk RJ, Lehman D., Klag M. et al. Race and sex differences in the distribution of cerebral atherosclerosis . Stroke1996; 27: 1974—80.
8.
Bogousslavsky J., Van MG, Regli F.The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. Stroke1988; 19: 1083—92.
9.
Foulkes MA, Wolf PA, Price TR et al. TheStroke Data Bank: design, methods, and baseline characteristics. Stroke1988; 19: 547—54.
10.
Inzitari D. , Eliasziw M., Gates P. et al. The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med2000; 342: 1693—700.
11.
Timsit SG, Sacco RL, Mohr JP et al. Early clinical differentiation of cerebral infarction from severe atherosclerotic stenosis and cardioembolism. Stroke1992; 23: 486—91.
12.
Osborn AGDiagnostic cerebral angiography. 2nd edn. 1999: Philadelphia, PA: Williams and Wilkins.
aCho L., Mukherjee D.Basic cerebral anatomy for the carotid interventionalist: The intracranial and extracranial vessels. Catheter Cardiovasc Interv2006; 68: 104—11.
17.
b White CJ, Ramee SR, Bendick PJ, Safian RDPeripheral vascular intervention: The Manual of Interventional Cardiology . 3rd edn. Royal Oak, MI: Physician' s Press, 2001: 831—901.
18.
O' Leary DH , Polak JF, Kronmal RA et al. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group. Stroke1992; 23: 1752—60.
19.
Muluk SC, Muluk VS, Sugimoto H. et al. Progression of asymptomatic carotid stenosis: a natural history study in 1004 patients. J Vasc Surg1999; 29: 208—14.
20.
North American Symptomatic Carotid Endarterectomy Trial Collaborators.Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med1991; 325: 445—53.
21.
Barnett HJ, Taylor DW, Eliasziw M. et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med1998; 339: 1415—25.
22.
Rothwell PM, Warlow CP, on behalf of the European carotid surgery trialists' collaborative group.Low risk of ischemic stroke in patients with reduced internal carotid artery lumen diameter distal to severe symptomatic carotid stenosis: cerebral protection due to low poststenotic flow? Stroke2000; 31: 622—30.
23.
Morgenstern LB, Fox AJ, Sharpe BL et al. The risks and benefits of carotid endarterectomy in patients with near occlusion of the carotid artery. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. Neurology1997; 48: 911—5.
24.
Executive Committee for the Asymptomatic Carotid Atherosclerosis Study.Endarterectomy for asymptomatic carotid artery stenosis. JAMA1995; 273: 1421—8.
25.
Halliday A. , Mansfield A., Marro J. et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet2004; 363: 1491—502.
26.
Eagle, KA, Guyton, RA, Davidoff R. et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery. A report of the American College of Cardiology /American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery) Available at: http://www.cardiosource.com/guidelines/browse.asp?topicID=7.
27.
Benavente O. , Eliasziw M., Streifler JY et al. Prognosis after transient monocular blindness associated with carotid-artery stenosis. N Engl J Med2001; 345: 1084—90.
28.
Kappelle LJ , Eliasziw M., Fox AJ, Sharpe BL, Barnett HJImportance of intracranial atherosclerotic disease in patients with symptomatic stenosis of the internal carotid artery. The North American Symptomatic Carotid Endarterectomy Trial. Stroke1999; 30: 282—6.
29.
Vernieri F. , Pasqualetti P., Matteis M. et al. Effect of collateral blood flow and cerebral vasomotor reactivity on the outcome of carotid artery occlusion. Stroke2001; 32: 1552—8.
30.
Gasecki AP, Eliasziw M., Ferguson GG et al. Long-term prognosis and effect of endarterectomy in patients with symptomatic severe carotid stenosis and contralateral carotid stenosis or occlusion: results from NASCET. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. J Neurosurg1995; 83: 778—82.
31.
Henderson RD , Eliasziw M., Fox AJ et al. Angiographically defined collateral circulation and risk of stroke in patients with severe carotid artery stenosis. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. Stroke2000; 31: 128—32.
32.
Polak JF, Shemanski L., O' Leary DH et al. Hypoechoic plaque at US of the carotid artery: an independent risk factor for incident stroke in adults aged 65 years or older. Cardiovascular Health Study. Radiology1998; 208: 649—54.
33.
Mathiesen EB , Bonaa KH, Joakimsen O.Echolucent plaques are associated with high risk of ischemic cerebrovascularVascular Medicine2007; 12: 35—83events in carotid stenosis: the tromso study. Circulation2001 ; 103: 2171—5.
34.
Sitzer M., Muller W., Siebler M. et al. Plaque ulceration and lumen thrombus are the main sources of cerebral microemboli in high-grade internal carotid artery stenosis. Stroke1995; 26: 1231—3.
35.
Streifler JY , Eliasziw M., Fox AJ et al. Angiographic detection of carotid plaque ulceration. Comparison with surgical observations in a multicenter study. North American Symptomatic Carotid Endarterectomy Trial. Stroke1994; 25: 1130—2.
36.
Johnston SC , Gress DR, Browner WS, Sidney S.Short-term prognosis after emergency department diagnosis of TIA. JAMA2000; 284: 2901—6.
37.
Lyden P., Raman R., Liu L. et al. NIHSS training and certification using a new digital video disk is reliable. Stroke2005; 36: 2446—9.
38.
Muir KW, Weir CJ, Murray GD et al. Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke1996; 27: 1817—20.
39.
European Carotid Surgery Trialists' Collaborative Group.MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70—99%) or with mild (0—29%) carotid stenosis. Lancet1991; 337: 1235—43.
40.
Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet1998; 351: 1379—87.
41.
Sabeti S., Schillinger M., Mlekusch W. et al. Quantification of internal carotid artery stenosis with duplex US: comparative analysis of different flow velocity criteria. Radiology2004; 232: 431—9.
42.
Bray JM, Galland F., Lhoste P. et al. Colour Doppler and duplex sonography and angiography of the carotid artery bifurcations. Prospective, double-blind study. Neuroradiology1995; 37: 219—24.
43.
Bluth EI, Sunshine JH, Lyons JB et al. Power Doppler imaging: initial evaluation as a screening examination for carotid artery stenosis. Radiology2000 ; 215: 791—800.
44.
Lovett JK, Redgrave JN, Rothwell PMA critical appraisal of the performance, reporting, and interpretation of studies comparing carotid plaque imaging with histology. Stroke2005; 36: 1091—7.
45.
Rothwell PM , Gibson R., Warlow CP, on behalf of the European Carotid Surgery Trialists' Collaborative Group.Interrelation between plaque surface morphology and degree of stenosis on carotid angiograms and the risk of ischemic stroke in patients with symptomatic carotid stenosis . Stroke2000; 31: 615—21.
46.
Biasi GM, Froio A., Diethrich EB et al. Carotid plaque echolucency increases the risk of stroke in carotid stenting: the Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS) study . Circulation2004; 110: 756—62.
47.
Kastelein JJ , de Groot E., Sankatsing R.Atherosclerosis measured by B-mode ultrasonography: effect of statin therapy on disease progression . Am J Med2004; 116(Suppl 6A): 31S—6S.
48.
Hodis HN, Mack WJ, LaBree L. et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med1998 ; 128: 262—9.
49.
Blakeley DD , Oddone EZ, Hasselblad V. et al. Noninvasive carotid artery testing. A meta-analytic review. Ann Intern Med1995 ; 122: 360—7.
50.
Grant EG, Benson CB, Moneta GL et al. Carotid artery stenosis: gray-scale and Doppler US diagnosis — Society of Radiologists in ultrasound consensus conference. Radiology2003; 229: 340—6.
51.
Comerota AJ, Salles-Cunha SX, Daoud Y. et al. Gender differences in blood velocities across carotid stenoses . J Vasc Surg2004; 40: 939—44.
52.
AbuRahma AF, Robinson PA, Strickler DL et al. Proposed new duplex classification for threshold stenoses used in various symptomatic and asymptomatic carotid endarterectomy trials. Ann Vasc Surg1998; 12: 349—58.
53.
Busuttil SJ, Franklin DP, Youkey JR, Elmore JRCarotid duplex overestimation of stenosis due to severe contralateral disease . Am J Surg1996; 172: 144—7.
54.
Fujitani RM, Kafie F.Screening and preoperative imaging of candidates for carotid endarterectomy . Semin Vasc Surg1999; 12: 261—74.
55.
Howard G., Baker WH, Chambless LE et al. An approach for the use of Doppler ultrasound as a screening tool for hemodynamically significant stenosis (despite heterogeneity of Doppler performance). A multicenter experience. Asymptomatic Carotid Atherosclerosis Study Investigators. Stroke1996; 27: 1951—7.
56.
Kuntz KM, Polak JF, Whittemore AD, Skillman JJ, Kent KCDuplex ultrasound criteria for the identification of carotid stenosis should be laboratory specific. Stroke1997; 28: 597—602.
57.
Alexandrov AVUltrasound and angiography in the selection of patients for carotid endarterectomy. Curr Cardiol Rep2003; 5: 141—7.
58.
Elgersma OE , van Leersum M., Buijs PC et al. Changes over time in optimal duplex threshold for the identification of patients eligible for carotid endarterectomy . Stroke1998; 29: 2352—6.
59.
Qureshi AI, Suri MF, Ali Z. et al. Role of conventional angiography in evaluation of patients with carotid artery stenosis demonstrated by Doppler ultrasound in general practice . Stroke2001; 32: 2287—91.
60.
Akers DL, Markowitz IA, Kerstein MDThe value of aortic arch study in the evaluation of cerebrovascular insufficiency . Am J Surg1987; 154: 230—2.
61.
Sitzer M., Rose G., Furst G. et al. Characteristics and clinical value of an intravenous echo-enhancement agent in evaluation of high-grade internal carotid stenosis. J Neuroimaging1997; 7(Suppl 1): S22—S25.
62.
Droste DW, Jurgens R., Weber S. et al. Benefit of echocontrastenhanced transcranial color-coded duplex ultrasound in the assessment of intracranial collateral pathways. Stroke2000; 31: 920—3.
63.
Ferrer JM, Samso JJ, Serrando JR et al. Use of ultrasound contrast in the diagnosis of carotid artery occlusion. J Vasc Surg2000; 31: 736—41.
64.
Paciaroni M. , Caso V., Cardaioli G. et al. Is ultrasound examination sufficient in the evaluation of patients with internal carotid artery severe stenosis or occlusion?Cerebrovasc Dis2003 ; 15: 173—6.
65.
Filis KA, Arko FR, Johnson BL et al. Duplex ultrasound criteria for defining the severity of carotid stenosis. Ann Vasc Surg2002; 16: 413—21.
66.
Mattos MA, Hodgson KJ, Faught WE et al. Carotid endarterectomy without angiography: is color-flow duplex scanning sufficient?Surgery1994; 116: 776—82.
67.
Patel MR, Kuntz KM, Klufas RA et al. Preoperative assessment of the carotid bifurcation. Can magnetic resonance angiography and duplex ultrasonography replace contrast arteriography?Stroke1995; 26: 1753—8.
68.
Navarro JC, Mikulik R., Garami Z., Alexandrov AVThe accuracy of transcranial Doppler in the diagnosis of stenosis or occlusion of the terminal internal carotid artery. J Neuroimaging2004; 14: 314—8.
69.
Sloan MA, Alexandrov AV, Tegeler CH et al. Assessment: transcranial Doppler ultrasonography: report of the therapeutics and technology assessment subcommittee of the American academy of neurology. Neurology2004; 62: 1468—81.
70.
Marshall RS , Rundek T., Sproule DM et al. Monitoring of cerebral vasodilatory capacity with transcranial Doppler carbon dioxide inhalation in patients with severe carotid artery disease. Stroke2003 ; 34: 945—9.
71.
Spence JD, Tamayo A., Lownie SP, Ng WP, Ferguson GGAbsence of microemboli on transcranial Doppler identifies low-risk patients with asymptomatic carotid stenosis. Stroke2005; 36: 2373—8.
72.
Wutke R., Lang W., Fellner C. et al. High-resolution, contrast-enhanced magnetic resonance angiography with elliptical centric k-space ordering of supra-aortic arteries compared with selective X-ray angiography. Stroke2002 ; 33: 1522—9.
73.
Alvarez-Linera J., Benito-Leon J., Escribano J., Campollo J., Gesto R.Prospective evaluation of carotid artery stenosis: elliptic centric contrast-enhanced MR angiography and spiral CT angiography compared with digital subtraction angiography. Am J Neuroradiol2003; 24: 1012—9.
74.
Remonda L., Senn P., Barth A. et al. Contrast-enhanced 3D MR angiography of the carotid artery: comparison with conventional digital subtraction angiography. Am J Neuroradiol2002; 23: 213—9.
75.
Cosottini M. , Pingitore A., Puglioli M. et al. Contrast-enhanced three-dimensional magnetic resonance angiography of atherosclerotic internal carotid stenosis as the noninvasive imaging modality in revascularization decision making. Stroke2003; 34: 660—4.
76.
DeMarco JK, Huston J. III, Bernstein MAEvaluation of classic 2D time-of-flight MR angiography in the depiction of severe carotid stenosis. AJR Am J Roentgenol2004; 183: 787—93.
77.
Long A., Lepoutre A., Corbillon E., Branchereau A.Critical review of non- or minimally invasive methods (duplex ultrasonography, MR- and CT-angiography) for evaluating stenosis of the proximal internal carotid artery. Eur J Vasc Endovasc Surg2002; 24: 43—52.
78.
Buskens E., Nederkoorn PJ, Buijs-Van Der WT et al. Imaging of carotid arteries in symptomatic patients: cost-effectiveness of diagnostic strategies. Radiology2004; 233: 101—12.
79.
Yuan C., Mitsumori LM, Ferguson MS et al. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation2001; 104: 2051—6.
80.
Rutt BK, Clarke SE, Fayad ZAAtherosclerotic plaque characterization by MR imaging. Curr Drug Targets Cardiovasc Haematol Disord2004; 4: 147—59.
81.
Glor FP, Ariff B., Crowe LA et al. Carotid geometry reconstruction: a comparison between MRI and ultrasound. Med Phys2003; 30: 3251—61.
82.
Teng MM, Tsai F., Liou AJ et al. Three-dimensional contrast-enhanced magnetic resonance angiography of carotid artery after stenting. J Neuroimaging2004; 14: 336—41.
83.
Gronholdt MLB-mode ultrasound and spiral CT for the assessment of carotid atherosclerosis. Neuroimaging Clin N Am2002; 12: 421—35.
84.
Belsky M., Gaitini D., Goldsher D., Hoffman A., Daitzchman M.Color-coded duplex ultrasound compared to CT angiography for detection and quantification of carotid artery stenosis. Eur J Ultrasound2000; 12: 49—60.
85.
Hollingworth W., Nathens AB, Kanne JP et al. The diagnostic accuracy of computed tomography angiography for traumatic or atherosclerotic lesions of the carotid and vertebral arteries: a systematic review. Eur J Radiol2003; 48: 88—102.
86.
Koelemay MJ, Nederkoorn PJ, Reitsma JB, Majoie CBSystematic review of computed tomographic angiography for assessment of carotid artery disease. Stroke2004; 35: 2306—12. 85 Addis KA, Hopper KD, Iyriboz TA et al. CT angiography: in vitro comparison of five reconstruction methods. AJR Am J Roentgenol2001; 177: 1171—6.
87.
Chen CJ, Lee TH, Hsu HL et al. Multi-slice CT angiography in diagnosing total versus near occlusions of the internal carotid artery: comparison with catheter angiography. Stroke2004; 35: 83—5.
88.
Rothwell PM , Eliasziw M., Gutnikov SA et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet2003; 361: 107—16.
89.
King-Im JM, Trivedi RA, Cross JJ et al. Measuring carotid stenosis on contrast-enhanced magnetic resonance angiography: diagnostic performance and reproducibility of 3 different methods . Stroke2004; 35: 2083—8.
90.
Connors JJ III, Sacks D., Furlan AJ et al. Training, competency, and credentialing standards for diagnostic cervicocerebral angiography, carotid stenting, and cerebrovascular intervention: a joint statement from the American Academy of Neurology, American Association of Neurological Surgeons, American Society of Interventional and Therapeutic Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, AANS/CNS Cerebrovascular Section, and Society of Interventional Radiology . Radiology2005; 234: 26—34.
91.
Fayed AM, White CJ, Ramee SR, Jenkins JS, Collins TJCarotid and cerebral angiography performed by cardiologists: cerebrovascular complications. Catheter Cardiovasc Interv2002; 55: 277—80.
92.
Leonardi M. , Cenni P., Simonetti L., Raffi L., Battaglia S.Retrospective study of complications arising during cerebral and spinal diagnostic angiography from 1998 to 2003. Interventional Neuroradiology2005; 11: 213—21.
93.
Smith S., Allen J.AHA/ACC secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2005 update. Circulation2006; 113: 2363—72.
94.
Sacco RL, Adams R., Albers G. et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke2006; 37: 577—617.
95.
Eastern Stroke and CoronaryHeart Disease Collaborative Research Group. Blood pressure, cholesterol, and stroke in eastern Asia. Lancet1998; 352: 1801—7.
96.
Vaccarino V. , Berger AK, Abramson J. et al. Pulse pressure and risk of cardiovascular events in the systolic hypertension in the elderly program. Am J Cardiol2001; 88: 980—6.
97.
Collins R., Peto R., MacMahon S. et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in
98.
blood pressure: overview of randomised drug trials in their epidemiological context. Lancet1990; 335: 827—38.
99.
Staessen JA , Gasowski J., Wang JG et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet2000; 355: 865—72.
100.
Chobanian AV , Bakris GL, Black HR et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high Blood Pressure: the JNC 7 report. JAMA2003; 289: 2560—72.
101.
Shinton R., Beevers G.Meta-analysis of relation between cigarette smoking and stroke. BMJ1989; 298: 789—94.
102.
Wolf PA, D' Agostino RB, Kannel WB, Bonita R., Belanger AJCigarette smoking as a risk factor for stroke. The Framingham Study . JAMA1988; 259: 1025—9.
103.
You RX, Thrift AG, McNeil JJ, Davis SM, Donnan GAIschemic stroke risk and passive exposure to spouses' cigarette smoking. Melbourne Stroke Risk Factor Study (MERFS) Group. Am J Public Health1999; 89: 572—5.
104.
Kawachi I. , Colditz GA, Stampfer MJ et al. Smoking cessation and decreased risk of stroke in women. JAMA1993; 269: 232—6.
105.
Fine-Edelstein JS, Wolf PA, O' Leary DH et al. Precursors of extracranial carotid atherosclerosis in the Framingham Study. Neurology1994; 44: 1046—50.
106.
Amarenco P. , Lavallee P., Touboul PJStroke prevention, blood cholesterol, and statins. Lancet Neurol2004 ; 3: 271—8.
107.
Kuller, LH, Dorman JS, Wolf PACerebrovascular Disease and Diabetes. Bethesda, MD: NIH Publication # 85—1468, 1985.
108.
Standards of medical care in diabetes. Diabetes Care2004; 27(Suppl 1): S15—35.
109.
Walker SP, Rimm EB, Ascherio A. et al. Body size and fat distribution as predictors of stroke among US men. Am J Epidemiol1996; 144: 1143—50.
110.
Rexrode KM , Hennekens CH, Willett WC et al. A prospective study of body mass index, weight change, and risk of stroke in women. JAMA1997; 277: 1539—45.
111.
Wilhelmsen L., Svardsudd K., Korsan-Bengtsen K. et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med1984; 311: 501—5.
112.
Rost NS, Wolf PA, Kase CS et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke2001; 32: 2575—9.
113.
Boushey CJ , Beresford SA, Omenn GS, Motulsky AGA quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA1995; 274: 1049—57.
114.
Further analyses of mortality in oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study. Lancet1981; 1: 541—6.
115.
Wolf PA, D' Agostino RB, Belanger AJ, Kannel WBProbability of stroke: a risk profile from the Framingham Study. Stroke1991; 22: 312—8.
116.
TheSALT Collaborative Group. Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet1991; 338: 1345—9.
117.
Farrell B. , Godwin J., Richards S., Warlow C.The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry1991; 54: 1044—54.
118.
TheDutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med1991; 325: 1261—6.
119.
Taylor DW, Barnett HJ, Haynes RB et al. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. ASA and Carotid Endarterectomy (ACE) Trial Collaborators. Lancet1999; 353: 2179—84.
120.
Diener HC, Cunha L., Forbes C. et al. European stroke prevention study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci1996; 143: 1—13.
121.
Halkes PH, van Gijn J., Kappelle LJ, Koudstaal PJ, Algra A.Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet2006; 367: 1665—73.
122.
Gent M., Blakely JA, Easton JD et al. The CanadianAmerican Ticlopidine Study (CATS) in thromboembolic stroke. Lancet1989; 1: 1215—20.
123.
Hass WK, Easton JD, Adams HP Jr. et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med1989; 321: 501—7. 122 CAPRIE Steering Committee.A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet1996; 348: 1329—39.
124.
Diener HC, Bogousslavsky J., Brass LM et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet2004; 364: 331—7.
125.
Bhatt DL, Fox KA, Hacke W. et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med2006 ; 354: 1706—17.
126.
Mohr JP, Thompson JL, Lazar RM et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med2001; 345: 1444—51.
127.
Chimowitz MI, Kokkinos J., Strong J. et al. TheWarfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology1995; 45: 1488—93.
128.
Ridker PM, Cook NR, Lee IM et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med2005; 352: 1293—304.
129.
Antithrombotic Trialists Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ2002; 324: 71—86.
130.
Albers GW, Amarenco P., Easton JD et al. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest2004; 126: 483S—512S.
131.
Rubins HB, Robins SJ, Collins D. et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans affairs high-density Lipoprotein Cholesterol intervention Trial Study Group. N Engl J Med1999; 341: 410—8.
132.
Canner PL, Berge KG, Wenger NK et al. Fifteen year mortality in coronary drug project patients: long-term benefit with niacin. J Am Coll Cardiol1986 ; 8: 1245—55.
133.
Collins R. , Armitage J., Parish S. et al. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet2004; 363: 757—67.
134.
Sever PS, Dahlof B., Poulter NR et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet2003; 361: 1149—58.
135.
White HD, Simes RJ, Anderson NE et al. Pravastatin therapy and the risk of stroke. N Engl J Med2000; 343: 317—26.
136.
McGirt MJ, Perler BA, Brooke BS et al. 3—hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy . J Vasc Surg2005; 42: 829—36.
137.
Amarenco P. , Bogousslavsky J., Callahan A. et al. Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study. Cerebrovasc Dis2003 ; 16: 389—95.
138.
a Amarenco P., Bogousslavsky J., Callahan AS III et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med2006; 355: 549—59.
139.
Grundy SM, Cleeman JI, Merz CN et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation2004; 110: 227—39.
140.
Statins after ischemic stroke and transient ischemic attack: an advisory statement from the Stroke Council, American Heart Association and American Stroke Association. Stroke2004 ; 35: 1023
141.
Yusuf S., Sleight P., Pogue J. et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med2000; 342: 145—53.
142.
Lonn E., Yusuf S., Dzavik V. et al. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation2001; 103: 919—25.
143.
PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet2001 ; 358: 1033—41.
144.
Lindholm LH , Ibsen H., Dahlof B. et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet2002; 359: 1004—10.
145.
Fisher M.Occlusion of the internal carotid artery. AMA Arch Neurol Psychiatry1951; 65: 346—77.
Eastcott HH , Pickering GW, Rob CGReconstruction of internal carotid artery in a patient with intermittent attacks of hemiplegia. Lancet1954; 267: 994—6.
148.
TheEC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. N Engl J Med1985; 313: 1191—200.
149.
Chambers BR , Norris JWThe case against surgery for asymptomatic carotid stenosis. Stroke1984; 15: 964—7.
150.
Mayberg MR, Wilson SE, Yatsu F. et al. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. Veterans affairs cooperative studies program 309 trialist group. JAMA1991; 266: 3289—94.
151.
Hobson RW, Weiss DG, Fields WS et al. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The veterans affairs cooperative study group. N Engl J Med1993; 328: 221—7.
152.
Tangkanakul C. , Counsell CE, Warlow CPLocal versus general anaesthesia in carotid endarterectomy: a systematic review of the evidence . Eur J Vasc Endovasc Surg1997; 13: 491—9.
153.
Cao P., De Rango P, Zannetti S.Eversion vs conventional carotid endarterectomy: a systematic review . Eur J Vasc Endovasc Surg2002; 23: 195—201.
154.
Ferguson GG , Eliasziw M., Barr HW et al. The NorthAmerican Symptomatic Carotid Endarterectomy Trial: surgical results in 1415 patients. Stroke1999; 30: 1751—8.
155.
Baker WH, Littooy FN, Hayes AC, Dorner DB, Stubbs D.Carotid endarterectomy without a shunt: the control series. J Vasc Surg1984; 1: 50—6.
156.
Gnanadev DA , Wang N., Comunale FL, Reile DACarotid artery stump pressure: how reliable is it in predicting the need for a shunt?Ann Vasc Surg1989; 3: 313—7.
157.
Schneider JR, Droste JS, Schindler N. et al. Carotid endarterectomy with routine electroencephalography and selective shunting: influence of contralateral internal carotid artery occlusion and utility in prevention of perioperative strokes. J Vasc Surg2002; 35: 1114—22.
158.
Counsell CE , Salinas R., Naylor R., Warlow CPA systematic review of the randomised trials of carotid patch angioplasty in carotid endarterectomy . Eur J Vasc Endovasc Surg1997; 13: 345—54.
159.
Ouriel K., Green RMClinical and technical factors influencing recurrent carotid stenosis and occlusion after endarterectomy. J Vasc Surg1987; 5: 702—6.
160.
Grego F., Antonello M., Lepidi S. et al. Prospective, randomized study of external jugular vein patch versus polytetrafluoroethylene patch during carotid endarterectomy: perioperative and long-term results. J Vasc Surg2003; 38: 1232—40.
161.
O' Hara PJ , Hertzer NR, Mascha EJ et al. A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy . J Vasc Surg2002; 35: 324—32.
162.
Bond R., Rerkasem K., Rothwell PMSystematic review of the risks of carotid endarterectomy in relation to the clinical indication for and timing of surgery. Stroke2003; 34: 2290—301.
163.
Bond R., Rerkasem K., Shearman CP, Rothwell PMTime trends in the published risks of stroke and death due to endarterectomy for symptomatic carotid stenosis. Cerebrovasc Dis2004; 18: 37—46.
164.
Feasby TE, Quan H., Ghali WAHospital and surgeon determinants of carotid endarterectomy outcomes . Arch Neurol2002; 59: 1877—81.
165.
Pearce WH, Parker MA, Feinglass J., Ujiki M., Manheim LMThe importance of surgeon volume and training in outcomes for vascular surgical procedures. J Vasc Surg1999; 29: 768—76.
166.
Chambers B. , Donnan G., Chambers B.Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database Syst Rev2005; CD001923.
167.
Barnett HJ , Eliasziw M., Meldrum HE, Taylor DWDo the facts and figures warrant a 10-fold increase in the performance of carotid endarterectomy on asymptomatic patients ? Neurology1996; 46: 603—8.
168.
Hsia DC, Moscoe LM, Krushat WMEpidemiology of carotid endarterectomy among Medicare beneficiaries: 1985—1996 update. Stroke1998; 29: 346—50.
169.
Wennberg DE , Lucas FL, Birkmeyer JD, Bredenberg CE, Fisher ESVariation in carotid endarterectomy mortality in the Medicare population: trial hospitals, volume, and patient characteristics . JAMA1998; 279: 1278—81.
170.
Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet2001 ; 357: 1729—37.
171.
Yadav JS, Wholey MH, Kuntz RE et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med2004; 351: 1493—501.
172.
Chaturvedi S.Should the multicenter carotid endarterectomy trials be repeated?Arch Neurol2003; 60: 774—5.
173.
Rothwell PM , Slattery J., Warlow CPA systematic review of the risks of stroke and death due to endarterectomy for symptomatic carotid stenosis. Stroke1996; 27: 260—5.
174.
Biller J., Feinberg WM, Castaldo JE et al. Guidelines for carotid endarterectomy: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation1998; 97: 501—9.
175.
Chaturvedi S., Bruno A., Feasby T. et al. Carotid endarterectomy— an evidence-based review: report of the Therapeutics and technology assessment subcommittee of theAmerican Academy of Neurology. Neurology2005; 65: 794—801.
176.
Rothwell PM , Eliasziw M., Gutnikov SA, Warlow CP, Barnett HJEndarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet2004; 363: 915—24.
177.
Bockenheimer SA, Mathias K.Percutaneous transluminal angioplasty in arteriosclerotic internal carotid artery stenosis. Am J Neuroradiol1983; 4: 791—2.
178.
Theron J., Raymond J., Casasco A., Courtheoux F.Percutaneous angioplasty of atherosclerotic and postsurgical stenosis of carotid arteries. Am J Neuroradiol1987 ; 8: 495—500.
179.
Theron J., Courtheoux P., Alachkar F., Bouvard G., Maiza D.New triple coaxial catheter system for carotid angioplasty with cerebral protection . Am J Neuroradiol1990; 11: 869—74.
180.
Wiggli U., Gratzl O.Transluminal angioplasty of stenotic carotid arteries: case reports and protocol . Am J Neuroradiol1983; 4: 793—5.
181.
Diethrich EB, Ndiaye M., Reid DBStenting in the carotid artery: initial experience in 110 patients. J Endovasc Surg1996; 3: 42—62.
182.
Marks MP, Dake MD, Steinberg GK, Norbash AM, Lane B.Stent placement for arterial and venous cerebrovascular disease: preliminary experience. Radiology1994; 191: 441—6.
183.
Roubin GS, New G., Iyer SS et al. Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-year prospective analysis. Circulation2001; 103: 532—7.
184.
Kastrup A. , Groschel K., Krapf H. et al. Early outcome of carotid angioplasty and stenting with and without cerebral protection devices: a systematic review of the literature. Stroke2003; 34: 813—9.
185.
Wholey MH, Al-Mubarek N., Wholey MHUpdated review of the global carotid artery stent registry. Catheter Cardiovasc Interv2003; 60: 259—66.
186.
Theiss W., Hermanek P., Mathias K. et al. Pro-CAS: a prospective registry of carotid angioplasty and stenting . Stroke2004; 35: 2134—9.
187.
Bosiers M., Peeters P., Deloose K. et al. Does carotid artery stenting work on the long run: 5-year results in high-volume centers (ELOCAS Registry). J Cardiovasc Surg (Torino)2005; 46: 241—7.
188.
White CJ, Iyer SS, Hopkins LN, Katzen BT, Russell MECarotid stenting with distal protection in high surgical risk patients: the BEACH trial 30 day results. Catheter Cardiovasc Interv2006; 67: 503—12.
189.
Safian RD, Bresnahan JF, Jaff MR et al. Protected carotid stenting in high-risk patients with severe carotid artery stenosis.. J Am Coll Cardiol2006; 47: 2384—9.
190.
Gray WA, Hopkins LN, Yadav S. et al. Protected carotid stenting in high surgical risk patients: the ARCHeR results. J Vasc Surg2006; 44: 258—68.
191.
Ramee S., Higashida R.Evaluation of the Medtronic self-expanding carotid stent system with distal protection in the treatment of carotid artery stenosis: the MAVErIC Trial Phase II 30-day update. (abstr) Am J Cardiol2004; 94: 61E.
192.
a Hopkins LNCABERNET. Oral presentation, EuroPCR Conference in Paris, France, May 26, 2005.
193.
b Gray WAARCHeR. Oral presentation, Amerian College of Cardiology Annual Scientific Session, Atlanta, GA, March 2006.
194.
Naylor AR, Bolia A., Abbott RJ et al. Randomized study of carotid angioplasty and stenting versus carotid endarterectomy: a stopped trial. J Vasc Surg1998; 28: 326—34.
195.
Alberts M.Results of a multicenter prospective randomized trial of carotid artery stenting vs. carotid endarterectomy. (abstr)Stroke2001; 32: 325d.
196.
Brooks WH, McClure RR, Jones MR et al. Carotid angioplasty and stenting versus carotid endarterectomy: randomized trial in a community hospital. J Am Coll Cardiol2001; 38: 1589—95.
197.
Brooks WH, McClure RR, Jones MR et al. Carotid angioplasty and stenting versus carotid endarterectomy for treatment of asymptomatic carotid stenosis: a randomized trial in a community hospital. Neurosurgery2004; 54: 318—24.
198.
Yadav JS, Sneed D., Ouriel K. et al. Durability of carotid stenting for the prevention of stroke: 3-year follow-up of the SAPPHIRE trial and the US Carotid Feasibility. (abstr) Circulation2005; 112(Suppl:II): 416.
199.
Coward LJ, Featherstone RL, Brown MMSafety and efficacy of endovascular treatment of carotid artery stenosis compared with carotid endarterectomy: a Cochrane systematic review of the randomized evidence. Stroke2005; 36: 905—11.
200.
Ringleb PA , Kunze A., Allenberg JR et al. TheStent-Supported Percutaneous Angioplasty of the Carotid Artery vs. Endarterectomy Trial. Cerebrovasc Dis2004; 18: 66—8.
201.
a Ringleb PA , Allenberg JR, Bruckmann H. et al. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet2006; 368: 1215—6.
202.
EVA-3S Investigators. Endarterectomy vs. Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial. Cerebrovasc Dis2004; 18: 62—5.
203.
Mas JL, Chatellier G., Beyssen B.Carotid angioplasty and stenting with and without cerebral protection: clinical alert from the Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis (EVA-3S) trial. Stroke2004; 35: e18—e20.
204.
a Mas JL, Chatellier G., Beyssen B. et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med2006 ; 355: 1726—9.
205.
Featherstone RL, Brown MM, Coward LJInternational carotid stenting study: protocol for a randomised clinical trial comparing carotid stenting with endarterectomy in symptomatic carotid artery stenosis. Cerebrovasc Dis2004; 18: 69—74.
206.
Hobson RWCREST (Carotid Revascularization Endarterectomy versus Stent Trial): background, design, and current status. Semin Vasc Surg2000; 13: 139—43.
207.
Hobson RW, Howard VJ, Roubin GS et al. Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase . J Vasc Surg2004; 40: 1106—11.
208.
CARESS Steering Committee. Carotid revascularization using endarterectomy or stenting systems (CARESS): phase I clinical trial. J Endovasc Ther2003; 10: 1021—30.
209.
CaRESS Steering Committee.Carotid Revascularization Using Endarterectomy or Stenting Systems (CaRESS) phase I clinical trial: 1-year results. J Vasc Surg2005; 42: 213—9.
210.
Schievink WISpontaneous dissection of the carotid and vertebral arteries. N Engl J Med2001; 344: 898—906.
211.
Cohen JE, Leker RR, Gotkine M., Gomori M., Ben-Hur T. Emergent stenting to treat patients with carotid artery dissection: clinically and radiologically directed therapeutic decision making . Stroke2003; 34: e254—e257.
212.
Houdart E. , Mounayer C., Chapot R., Saint-Maurice JP, Merland JJCarotid stenting for radiation-induced stenoses: a report of 7 cases. Stroke2001; 32: 118—21.
213.
Finsterer J., Strassegger J., Haymerle A., Hagmuller G.Bilateral stenting of symptomatic and asymptomatic internal carotid artery stenosis due to fibromuscular dysplasia. J Neurol Neurosurg Psychiatry2000; 69: 683—6.
214.
Sharma BK, Jain S., Bali HK, Jain A., Kumari S.A follow-up study of balloon angioplasty and de-novo stenting in Takayasu arteritis. Int J Cardiol2000; 75(Suppl 1): S147-S152.
215.
Roubin GS, Iyer S., Halkin A., Vitek J., Brennan C.Realizing the potential of carotid artery stenting: proposed paradigms for patient selection and procedural technique. Circulation2006; 113: 2021—30.
216.
Blacker DJ , Flemming KD, Link MJ, Brown RD Jr. The preoperative cerebrovascular consultation: common cerebrovascular questions before general or cardiac surgery. Mayo Clin Proc2004; 79: 223—9.
217.
Stanziale SF, Marone LK, Boules TN et al. Carotid artery stenting in octogenarians is associated with increased adverse outcomes. J Vasc Surg2006; 43: 297—304.
218.
Naylor AR, Mehta Z., Rothwell PM, Bell PRCarotid artery disease and stroke during coronary artery bypass: a critical review of the literature. Eur J Vasc Endovasc Surg2002; 23: 283—94.
219.
Kasner SE, Chimowitz MI, Lynn MJ et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation2006; 113: 555—63.
220.
Bush RL, Lin PH, Mureebe L. et al. Routine bivalirudin use in percutaneous carotid interventions . J Endovasc Ther2005; 12: 521—2.
221.
Kapadia SR, Bajzer CT, Ziada KM et al. Initial experience of platelet glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting: a safe and effective adjunctive therapy . Stroke2001; 32: 2328—32.
222.
Wholey MH, Wholey MH, Eles G. et al. Evaluation of glycoprotein IIb/IIIa inhibitors in carotid angioplasty and stenting. J Endovasc Ther2003; 10: 33—41.
223.
Rosenfield K. , Babb JD, Cates CU et al. Clinical competence statement on carotid stenting: training and credentialing for carotid stenting— multispecialty consensus recommendations: a report of the SCAI/SVMB/SVS Writing Committee to Develop a Clinical Competence Statement on Carotid Interventions . J Am Coll Cardiol2005; 45: 165—74.
224.
Barr JD, Connors JJ III, Sacks D. et al. Quality improvement guidelines for the performance of cervical carotid angioplasty and stent placement. J Vasc Interv Radiol2003; 14: S321—S335.
225.
Beller GA, Bonow RO, Fuster V.ACC revised recommendations for training in adult cardiovascular medicine . Core
226.
Cardiology Training II (COCATS 2). (Revision of the 1995 COCATS training statement) . J Am Coll Cardiol2002; 39: 1242—6.
227.
Creager MA , Goldstone J., Hirshfeld JW Jr. et al. ACC/ACP/SCAI/SVMB/SVS clinical competence statement on vascular medicine and catheter-based peripheral vascular interventions: a report of the American College of Cardiology/American Heart Association/American College of Physician Task Force on Clinical Competence (ACC/ACP/SCAI/SVMB/SVS Writing Committee to Develop a Clinical Competence Statement on Peripheral Vascular Disease). J Am Coll Cardiol2004; 44: 941—57.
228.
Seymour NE , Gallagher AG, Roman SA et al. Virtual reality training improves operating room performance: results of a randomized, double-blinded study. Ann Surg2002; 236: 458—63.
229.
Patel A., Gallagher A., Nicholson W., Cates CULearning curves and reliability measures for virtual reality simulation in the performance assessment of carotid angiography. J Am Coll Cardiol2006; 47: 1796—802.